OPM cites an aging federal workforce with more chronic conditions and prescription drug usage, including GLP-1 medications prescribed for weight loss, as contributors to the premium increase
making sure that the bad actors get weeded out, and that the good actors can continue to do the good work that they're doing. The opportunities ahead: combination therapies In my 50 years in life sciences research, Ive often observed that for every ten people focused on what stands in the way, there is usually only one who can identify the opportunities and inspiration for moving ahead. Richard DiMarchi Distinguished Professor and Gill Chair in Biomolecular Sciences at Indiana University was invited to the workshop to discuss challenges, but he thought it more prudent to focus on opportunities
Branded versions like Rybelsus have been through the standard FDA approval process for specific uses, such as managing type 2 diabetes
But no machine can replace the human magic of a warm, confident, experienced touch
The cool thing about glucagon, it's basically making the liver break down glycogen, [which is] stored sugar, Dr
